98 related articles for article (PubMed ID: 596167)
1. Aseptic work under various hygienic conditions.
Aslund B; Olson OT; Sandell E
Acta Pharm Suec; 1977; 14(5-6):517-24. PubMed ID: 596167
[No Abstract] [Full Text] [Related]
2. Continuous microbiological air monitoring for aseptic filling lines.
Ginsbury K
PDA J Pharm Sci Technol; 2007; 61(4):225. PubMed ID: 17933205
[No Abstract] [Full Text] [Related]
3. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control.
Elias WF
Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322
[No Abstract] [Full Text] [Related]
4. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
Raiman HL
Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
[No Abstract] [Full Text] [Related]
5. Aseptic methods for removing fluids from small-volume parenterals.
Nagata RE; Mock ED; Reynolds G; Moriyama W; Schalker WL
Hosp Pharm; 1977 Mar; 12(3):118-9, 122-6. PubMed ID: 10235811
[No Abstract] [Full Text] [Related]
6. [Microbiological aspects of the pharmaceutical environment].
Buogo A; Guerrato G; Giulioni A; Papakristo G
Boll Chim Farm; 1979 Jan; 118(1):9-17. PubMed ID: 454532
[No Abstract] [Full Text] [Related]
7. The biotest RCS air samplers in unidirectional flow.
Ljungqvist B; Reinmüller B
J Pharm Sci Technol; 1994; 48(1):41-4. PubMed ID: 8004418
[TBL] [Abstract][Full Text] [Related]
8. Interaction between air movements and the dispersion of contaminants: clean zones with unidirectional air flow.
Ljungqvist B; Reinmüller B
J Parenter Sci Technol; 1993; 47(2):60-9. PubMed ID: 8515346
[TBL] [Abstract][Full Text] [Related]
9. [Microbiological in-process control in drug manufacture].
Seyfarth VH
Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
[TBL] [Abstract][Full Text] [Related]
10. [Flow of laminar air: use in sterile rooms].
Lumini E
Boll Chim Farm; 1975 Jul; 114(7):361-74. PubMed ID: 1164445
[No Abstract] [Full Text] [Related]
11. [On the use of laminar glow devices in pharmacies (author's transl)].
Naumann H
Pharmazie; 1980 Jan; 35(1):55-60. PubMed ID: 7384177
[TBL] [Abstract][Full Text] [Related]
12. Environmental microbial challenges to an aseptic Blow-Fill-Seal process--a practical study.
Jones DJ; Topping P; Sharp J
PDA J Pharm Sci Technol; 1995; 49(5):226-34. PubMed ID: 7489196
[TBL] [Abstract][Full Text] [Related]
13. Continuous microbiological air monitoring for aseptic filling lines.
Scherwing C; Golin F; Guenec O; Pflanz K; Dalmaso G; Bini M; Andone F
PDA J Pharm Sci Technol; 2007; 61(2):102-9. PubMed ID: 17479718
[TBL] [Abstract][Full Text] [Related]
14. The influence of clean room design on product contamination.
Whyte W
J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777
[No Abstract] [Full Text] [Related]
15. [Prescription preparation of microbially uncontaminated eyedrops eye ointments. 3].
Frauch P
Pharm Acta Helv; 1970 Jun; 45(6):329-44. PubMed ID: 5426097
[No Abstract] [Full Text] [Related]
16. Pharmaceutical sterility testing.
Parisi AN; Borick PM
Contam Control; 1969 Jan; 8(1):31-4. PubMed ID: 4237573
[No Abstract] [Full Text] [Related]
17. Control of the aseptic processing environment.
Frieben WR
Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
[TBL] [Abstract][Full Text] [Related]
18. Design control and validation of a facility for sterile clinical trial preparations.
Staines L
J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
[No Abstract] [Full Text] [Related]
19. Aerobiological model for assessing microbial contamination.
Lipscomb B; Avis KE
J Parenter Drug Assoc; 1979; 33(1):3-16. PubMed ID: 253025
[No Abstract] [Full Text] [Related]
20. [Control of microbial contamination in the air of rooms for sterile production. Proposals for sampling].
Carazzone M; Fava M
Boll Chim Farm; 1981 Jul; 120(7):416-26. PubMed ID: 7317168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
